Johnson Financial Group, Inc. Exact Sciences Corp Transaction History

Johnson Financial Group, Inc.

  • $2.19 Billion
  • Q3 2024

A detailed history of Johnson Financial Group, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Johnson Financial Group, Inc. holds 235 shares of EXAS stock, worth $12,471. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235
Previous 349 32.66%
Holding current value
$12,471
Previous $14,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$42.43 - $70.83 $4,837 - $8,074
-114 Reduced 32.66%
235 $16,000
Q2 2024

Aug 14, 2024
BUY
$41.33 - $74.26 $7,728 - $13,886
187 Added 115.43%
349 $14,000
Q1 2024

May 14, 2024
SELL
$56.27 - $73.77 $289,058 - $378,956
-5,137 Reduced 96.94%
162 $11,000
Q4 2023

Feb 09, 2024
BUY
$59.06 - $75.72 $294,945 - $378,145
4,994 Added 1637.38%
5,299 $392,000
Q3 2023

Nov 14, 2023
SELL
$65.94 - $99.04 $41,410 - $62,197
-628 Reduced 67.31%
305 $20,000
Q2 2023

Aug 14, 2023
SELL
$62.68 - $95.05 $49,203 - $74,614
-785 Reduced 45.69%
933 $87,000
Q1 2023

May 12, 2023
SELL
$47.19 - $70.77 $36,336 - $54,492
-770 Reduced 30.95%
1,718 $116,000
Q3 2022

Nov 14, 2022
SELL
$31.97 - $49.37 $14,993 - $23,154
-469 Reduced 15.86%
2,488 $86,000
Q2 2022

Aug 15, 2022
SELL
$35.61 - $76.23 $13,104 - $28,052
-368 Reduced 11.07%
2,957 $117,000
Q1 2022

May 16, 2022
SELL
$57.56 - $82.54 $80,296 - $115,143
-1,395 Reduced 29.56%
3,325 $232,000
Q3 2021

Nov 12, 2021
SELL
$90.24 - $124.05 $9,024 - $12,405
-100 Reduced 2.07%
4,720 $451,000
Q2 2021

Aug 13, 2021
SELL
$93.66 - $139.27 $20,605 - $30,639
-220 Reduced 4.37%
4,820 $599,000
Q1 2021

May 14, 2021
BUY
$116.57 - $155.01 $19,000 - $25,266
163 Added 3.34%
5,040 $664,000
Q4 2020

Feb 12, 2021
SELL
$99.61 - $142.12 $24,902 - $35,530
-250 Reduced 4.88%
4,877 $646,000
Q3 2020

Nov 12, 2020
SELL
$72.92 - $102.01 $12,177 - $17,035
-167 Reduced 3.15%
5,127 $522,000
Q1 2020

May 14, 2020
BUY
$37.9 - $104.44 $9,550 - $26,318
252 Added 5.0%
5,294 $307,000
Q4 2019

Feb 14, 2020
SELL
$77.66 - $99.74 $18,250 - $23,438
-235 Reduced 4.45%
5,042 $466,000
Q3 2019

Nov 12, 2019
BUY
$90.37 - $122.49 $10,844 - $14,698
120 Added 2.33%
5,277 $477,000
Q2 2019

Aug 09, 2019
BUY
$89.51 - $118.04 $26,853 - $35,412
300 Added 6.18%
5,157 $609,000
Q1 2019

May 13, 2019
BUY
$61.98 - $96.5 $17,664 - $27,502
285 Added 6.23%
4,857 $421,000
Q1 2018

May 07, 2018
SELL
$39.82 - $57.53 $1,592 - $2,301
-40 Reduced 0.87%
4,572 $184,000
Q4 2017

Feb 12, 2018
SELL
$46.49 - $60.51 $11,622 - $15,127
-250 Reduced 5.14%
4,612 $242,000
Q3 2017

Nov 09, 2017
BUY
$37.05 - $47.12 $180,137 - $229,097
4,862
4,862 $229,000

Others Institutions Holding EXAS

# of Institutions
670
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.39B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Johnson Financial Group, Inc. Portfolio

Follow Johnson Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Johnson Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Johnson Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email